Reviva Pharmaceuticals (RVPHW) Stock Chart & Stock Price History $0.03 +0.00 (+6.56%) Closing price 08/8/2025 07:00 AM EasternExtended Trading$0.03 0.00 (0.00%) As of 08/8/2025 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Reviva Pharmaceuticals Stock Price Performance The Reviva Pharmaceuticals (RVPHW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.50%, with a year-to-date return of -80.23%. In the past month, the stock has decreased 7.14%, reflecting recent market activity. As of the latest close, Reviva Pharmaceuticals traded at $0.03 with a market cap of and volume of 126,200 shares. Receive RVPHW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.56%1 Month Performance-7.14%3 Month Performance-35.00%Year-To-Date Performance-80.23%1 Year Performance-67.50% RVPHW Stock Chart for Sunday, August, 10, 2025 RVPHW Chart by TradingView Reviva Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$0.03$0.03+6.56%$0.03$0.03126,200 shs$0.0008/07/2025$0.03$0.03+0.33%$0.03$0.03125,562 shs$0.0008/06/2025$0.03$0.03-0.33%$0.03$0.032,575 shs$0.0008/05/2025$0.03$0.03-3.48%$0.03$0.036,639 shs$0.0008/04/2025$0.03$0.03+4.29%$0.03$0.03115,099 shs$0.0008/01/2025$0.03$0.03-1.62%$0.03$0.0313,755 shs$0.0007/31/2025$0.03$0.03-11.75%$0.03$0.035,586 shs$0.0007/30/2025$0.04$0.03-5.93%$0.03$0.034,797 shs$0.0007/29/2025$0.04$0.04+1.09%$0.04$0.03114,554 shs$0.0007/28/2025$0.03$0.04+21.12%$0.04$0.03125,227 shs$0.00 Get the Latest News and Ratings for RVPHW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$0.03$0.03+6.69%$0.03$0.0324,363 shs$0.0007/24/2025$0.03$0.03-10.97%$0.03$0.038,156 shs$0.0007/23/2025$0.03$0.03+2.57%$0.03$0.033,828 shs$0.0007/22/2025$0.03$0.03-4.89%$0.03$0.0318,207 shs$0.0007/21/2025$0.03$0.03+0.62%$0.04$0.0319,992 shs$0.0007/18/2025$0.03$0.03-2.99%$0.04$0.0334,757 shs$0.0007/17/2025$0.04$0.03-4.29%$0.04$0.0319,731 shs$0.0007/16/2025$0.04$0.04-3.58%$0.04$0.048,485 shs$0.0007/15/2025$0.04$0.04+3.12%$0.04$0.042,583 shs$0.0007/14/2025$0.04$0.04+0.57%$0.04$0.0423,044 shs$0.0007/11/2025$0.04$0.04$0.04$0.046,403 shs$0.0007/10/2025$0.03$0.04+1.45%$0.04$0.0369,607 shs$0.0007/09/2025$0.03$0.03+4.55%$0.04$0.0352,335 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart BriaCell Therapeutics Stock Price Chart Calithera Biosciences Stock Price Chart Receive RVPHW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RVPHW) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
